E
EBioinformatics
Bioinformatics services to the worldwide bioscience research efforts
About EBioinformatics
EBioinformatics was an Australian bioinformatics company established in 1998 by Founder and Chief Scientific Officer, Tim Littlejohn. Headquartered in Sydney, the firm focused on providing services for genome and sequence analysis to the global bioscience research community. The company operated on a subscription-based business model, offering access to its proprietary tools and platforms.
The core of its offering was Bionavigator, an application service provider (ASP) workspace designed for analyzing genomic sequences. This platform integrated BLAST (Basic Local Alignment Search Tool) functionalities, allowing researchers to perform complex sequence comparisons. To enhance the capabilities of its workspace, EBioinformatics partnered with Molsoft to incorporate ICM software, aiming to improve efficiency in genome analysis. The company's revenue model involved offering one-month trial programs for Bionavigator, which would then convert to paid subscriptions for continued use.
Despite its efforts in a competitive field, EBioinformatics did not secure any funding rounds and is now considered a deadpooled company.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 1999
- Headquarters
- Pleasanton, United States
- Open positions
- None listed
- Dealroom signal
- 17.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2000 | $10M | $40M | 3i Group · CSL · International Biotechnology Trust | — |
Growth signals
Latest recorded traffic for EBioinformatics is 0 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
3i Group
CSL
International Biotechnology Trust
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about EBioinformatics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EBioinformatics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.